Plasma pharmacokinetics of once-daily abacavir- and lamivudine-containing regimens and week 96 efficacy in HIV-infected Thai children

BACKGROUND: Abacavir and lamivudine are approved for once-daily use in HIV-infected adults. Limited pharmacokinetic (PK) data for abacavir and lamivudine in children are available. METHODS: A crossover study to compare PK of once- versus twice-daily abacavir and lamivudine was conducted in virologic...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Virus Erad
Main Authors: Bunupuradah, Torsak, Punyahotra, Passorn, Cressey, Tim R, Srimuan, Amornrat, Thammajaruk, Narukjaporn, Sophonphan, Jiratchaya, Sriheara, Chulalak, Burger, David M, Puthanakit, Thanyawee, Ananworanich, Jintanat
Formato: Artigo
Idioma:Inglês
Publicado em: Mediscript Ltd 2015
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4946738/
https://ncbi.nlm.nih.gov/pubmed/27482411
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados